08/28/2014 - 9:01am

Walgreens on Wednesday announced a tetanus, diphtheria, pertussis (Tdap) vaccination voucher program, in collaboration with the Alaska Department of Health and Social Services, to help protect against pertussis (whooping cough). 

08/27/2014 - 4:11pm

Canada's Premiers gathered in Charlottetown for the latest Council of the Federation meeting starting on Aug. 26, and health reform is a key topic. The pharmacy community is urging provinces to consider further expanding pharmacists' role as they can make important contributions to improving patient outcomes, reducing costs and ensuring the sustainability of the health care system.

08/27/2014 - 4:10pm

Greenway Health on Wednesday announced the completion of one of the largest centralized pharmacy cloud-based electronic health record systems ever deployed, Walgreens Cloud EHR.

08/27/2014 - 2:16pm

Low-dose aspirin lowers the occurrence of new venous blood clots — and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new study published in Monday's issue of Circulation.

08/27/2014 - 1:44pm

The International Society for Pharmaceutical Engineering on Wednesday announced that it has released a preview of its Drug Shortages Prevention Plan aimed at helping the pharmaceutical industry avoid drug shortages and maintain a reliable supply of medications. 

08/27/2014 - 10:08am

CVS Caremark has entered into a new clinical affiliation with MedStar Health, a healthcare system with 10 hospitals in Maryland and the Washington, D.C., region.

08/27/2014 - 9:50am

A&D Medical on Wednesday launched its WellnessConnected platform to help people monitor their physical activity and better manage their health.

08/27/2014 - 8:54am

GlaxoSmithKline announced that the Food and Drug Administration approved its supplemental new drug application for Promacta (eltrombopag), a once-daily medication for patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.

08/26/2014 - 11:51am

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. announced that Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States.